Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epelsiban Safety and PK in Healthy Females
NCT02257359Phase 1Completed
- Sponsor
- GSK
- Start
- Dec 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of epelsiban in infertility (3 arms), sponsored by GSK. Primary endpoints: Composite pharmacokinetic parameters of epelsiban and its metabolite (GSK2395448), Number of subjects with Adverse events (AEs) and 7 more. Started Dec 2014; status: completed.
02
Drugs
epelsiban
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02257359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257359.